Axa Equitable Holdings Stock Current Liabilities
| EQH Stock | USD 54.41 0.26 0.48% |
Axa Equitable Holdings fundamentals help investors to digest information that contributes to Axa Equitable's financial success or failures. It also enables traders to predict the movement of Axa Stock. The fundamental analysis module provides a way to measure Axa Equitable's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axa Equitable stock.
Axa |
Axa Equitable Holdings Company Current Liabilities Analysis
Axa Equitable's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Axa Equitable Holdings has a Current Liabilities of 0.0. This is 100.0% lower than that of the Financial Services sector and about the same as Financials (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Axa Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axa Equitable's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axa Equitable could also be used in its relative valuation, which is a method of valuing Axa Equitable by comparing valuation metrics of similar companies.Axa Equitable is currently under evaluation in current liabilities category among its peers.
Axa Fundamentals
| Return On Equity | 0.0433 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 14.65 B | ||||
| Shares Outstanding | 313.34 M | ||||
| Shares Owned By Insiders | 0.46 % | ||||
| Shares Owned By Institutions | 99.60 % | ||||
| Number Of Shares Shorted | 4.41 M | ||||
| Price To Earning | 3.79 X | ||||
| Price To Book | 10.23 X | ||||
| Price To Sales | 1.58 X | ||||
| Revenue | 10.53 B | ||||
| Gross Profit | 2 B | ||||
| EBITDA | 2.21 B | ||||
| Net Income | 1.3 B | ||||
| Cash And Equivalents | 4.28 B | ||||
| Cash Per Share | 15.03 X | ||||
| Total Debt | 5.63 B | ||||
| Debt To Equity | 0.71 % | ||||
| Current Ratio | 2.58 X | ||||
| Book Value Per Share | 5.25 X | ||||
| Cash Flow From Operations | (208 M) | ||||
| Short Ratio | 1.74 X | ||||
| Earnings Per Share | (0.91) X | ||||
| Price To Earnings To Growth | 1.71 X | ||||
| Target Price | 57.73 | ||||
| Number Of Employees | 8.5 K | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 17 B | ||||
| Total Asset | 276.81 B | ||||
| Retained Earnings | 10.24 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 276.81 B | ||||
| Last Dividend Paid | 0.22 |
About Axa Equitable Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axa Equitable Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axa Equitable using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axa Equitable Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Axa Equitable Piotroski F Score and Axa Equitable Altman Z Score analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.